The phase-1 human clinical trials of the two COVID-19 vaccine candidates, developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research and Zydus Cadila Ltd, have been completed and the trials have moved to phase 2, ICMR Director General Balram Bhargava said last Tuesday.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3kxdySa
via IFTTT
0 comments:
Post a Comment